Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

908 Devices Inc (NQ: MASS )

3.620 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,912
Open 3.620
Bid (Size) 3.000 (1)
Ask (Size) 3.300 (1)
Prev. Close 3.620
Today's Range 3.620 - 3.620
52wk Range 3.130 - 12.51
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
908 Devices Reports Third Quarter 2024 Financial Results and Updates 2024 Revenue Outlook
From 908 Devices Inc.
Via Business Wire
Earnings Scheduled For November 12, 2024
Via Benzinga

Performance

YTD
-63.51%
-63.51%
1 Month
+4.32%
+4.32%
3 Month
-14.82%
-14.82%
6 Month
-44.82%
-44.82%
1 Year
-35.93%
-35.93%

More News

Read More
908 Devices to Participate in Upcoming Investor Conferences
From 908 Devices Inc.
Via Business Wire
908 Devices to Report Third Quarter 2024 Financial Results on November 12, 2024
From 908 Devices Inc.
Via Business Wire
908 Devices Earnings Preview
Via Benzinga
908 Devices to Participate in Craig-Hallum Bioprocessing Conference
From 908 Devices Inc.
Via Business Wire
MASS Stock Earnings: 908 Devices Misses EPS, Beats Revenue for Q2 2024
Via InvestorPlace
908 Devices Reports Second Quarter 2024 Financial Results and Reiterates 2024 Revenue Outlook
From 908 Devices Inc.
Via Business Wire
908 Devices to Participate in Canaccord Genuity 44th Annual Growth Conference
From 908 Devices Inc.
Via Business Wire
908 Devices to Report Second Quarter 2024 Financial Results on August 6, 2024
From 908 Devices Inc.
Via Business Wire
908 Devices Appoints Michele M. Leonhart, Former Administrator of the United States Drug Enforcement Administration (DEA), to Its Board of Directors
From 908 Devices Inc.
Via Business Wire
908 Devices Enhances XplorIR Portable Analyzer to Simultaneously Identify and Quantify Hazardous Gases and Vapors
From 908 Devices Inc.
Via Business Wire
908 Devices to Participate in Upcoming Investor Conferences
From 908 Devices Inc.
Via Business Wire
12 Information Technology Stocks Moving In Tuesday's After-Market Session
Via Benzinga
$2.8M Bet On Aon? Check Out These 3 Stocks Insiders Are Buying
Via Benzinga
MASS Stock Earnings: 908 Devices Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
12 Information Technology Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
908 Devices Reports First Quarter 2024 Financial Results and Updates 2024 Revenue Outlook
From 908 Devices Inc.
Via Business Wire
908 Devices Acquires RedWave Technology, Expanding its Forensics Product Offering
From 908 Devices Inc.
Via Business Wire
908 Devices to Report First Quarter 2024 Financial Results on April 30, 2024
From 908 Devices Inc.
Via Business Wire
908 Devices Trace Chemical Identification Technology Adopted by European Agencies
From 908 Devices Inc.
Via Business Wire
Cathie Wood Sells $13.15M Worth Of Coinbase Shares Amid Bitcoin Flirting With All-Time High Levels — Shops For Palantir Stock Instead
Via Benzinga
908 Devices Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Revenue Outlook
From 908 Devices Inc.
Via Business Wire
Earnings Scheduled For March 5, 2024
Via Benzinga
908 Devices and Cellares Collaborate to Integrate In-line Monitoring of Bioprocess Parameters into the Cell Shuttle, Cellares’ Fully Integrated Cell Therapy Manufacturing Platform
From 908 Devices Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.